Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRA | P10827 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13508830 | 0.90 | ALDH1A1 (0.39) | ALDH1A1PPARGPPARAXDHPPARD | |
| SCHEMBL20169877 | 0.81 | S1PR5 (0.39) | KDM1AXDHPPARD | |
| SCHEMBL20169876 | 0.81 | S1PR5 (0.39) | KDM1AXDHPPARD | |
| SCHEMBL15918783 | 0.81 | ALDH1A1 (0.38) | ALDH1A1PPARGPPARAPPARD | |
| SCHEMBL16160557 | 0.80 | CYP3A4 (0.53) | ALDH1A1KDM1A | |
| SCHEMBL16160606 | 0.80 | CYP3A4 (0.53) | ALDH1A1KDM1A | |
| SCHEMBL15918843 | 0.78 | ALDH1A1 (0.36) | ALDH1A1PPARGPPARAPPARD | |
| SCHEMBL14415238 | 0.77 | SLC5A2 (0.35) | ALDH1A1 | |
| SCHEMBL14415237 | 0.77 | SLC5A2 (0.35) | ALDH1A1 | |
| SCHEMBL14626184 | 0.77 | SLC5A2 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160039781-A1 | NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS | SPHAERA PHARMA PVT. LTD. (SG) | 2016-02-11 | — | — | US | disclosed |
| WO-2014162320-A2 | NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS | SPHAERA PHARMA PVT. LTD. (IN) | 2014-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039781-A1 | NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS | PGC, TEAD3, TEAD4 | FAAH 3356/4885ALDH1A1 2886/4885THRA 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.